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Background/aim: Ovarian transplantation can preserve fertility in cancer patients. The aim of this study was to compare ovarian
transplantation into granulation tissue (GT) versus back muscle (BM) sites and also to investigate the effects of N-acetylcysteine (NAC)
as an antioxidant on ovarian survival in a rat autograft model.
Materials and methods: Twenty-eight adult female rats were divided into four equal groups (n = 7 each) as follows: Group 1, ovarian
tissue grafted into GT + saline (GT + saline); Group 2, ovarian tissue grafted into GT + NAC (GT + NAC); Group 3, ovarian tissue
grafted into BM + saline (BM + saline); and Group 4, ovarian tissue grafted into BM + NAC (BM + NAC). After 28 days, serum
concentrations of malondialdehyde (MDA), progesterone, and estradiol (E2) were measured. Ovarian follicle counts were performed
from hematoxylin and eosin-stained slides. Furthermore, apoptosis was assessed by terminal deoxynucleotidyl transferase (TdT) dUTP
nick-end labeling (TUNEL).
Results: There were no significant differences found in levels of MDA, progesterone, and E2 among the groups. The percentage of
apoptotic granulosa cells was significantly (P < 0.05) lower in the ovarian tissue autografted in the GT + NAC group compared to the
GT + saline and BM + NAC groups. In addition, the number of blood vessels formed in the ovarian tissue in the GT + NAC group was
significantly higher than in the GT + saline and BM + NAC groups (P < 0.05 and P < 0.001 respectively).
Conclusion: The granulation tissue site is a suitable candidate for ovarian graft in rats. Furthermore, NAC could not restore autografted
ovarian functions.
Key words: Ovarian tissue autograft, granulation tissue, N-acetylcysteine, back muscle, rats

1. Introduction
Recent advances in cancer treatment have significantly
increased the number of cancer survivors. Cancer
treatments such as chemotherapy and radiotherapy
threaten reproductive potential, resulting in premature
ovarian failure and infertility (1,2).
Ovarian tissue transplantation has been performed
to restore fertility among infertile cancer survivors who
have undergone chemo/radiotherapy; however, despite
these promising findings, there still exist some unresolved
limitations that affect the success of transplantation (3,4).
Ischemia/reperfusion (IR) injury during the first few
days after transplantation is the most important challenge
in ovarian tissue transplantation that leads to oxidative
stress, cytokine release, and apoptosis, resulting in massive
follicular loss in the transplanted ovary (5–7). Therefore,
using any means to reduce ischemic injury during the
transplantation period and enhancing angiogenesis in the
* Correspondence: mojtaba_karimipour@yahoo.com

ovarian grafts can play a vital role in the success of the
ovarian tissue transplantation.
It has been proven that the survival of a grafted ovary
is strongly correlated with the neovascularization process.
Accordingly, one suggestion is to activate this process after
ovarian transplantation, especially during the first few
days, because this process can take 2–7 days to complete
(8,9).
Selection of the ovarian transplantation site is another
important factor involved in the future of graft survival.
Therefore, it is important to determine which site is the
most suitable for maintaining graft viability and function.
The ovary can be transplanted into its original site
(orthotopic) or to other sites (heterotopic) (5). Easy access
for oocyte collection and noninvasiveness of the surgical
technique are the advantages of heterotopic sites that
should be considered (10).
Many studies have reported several heterotopic sites
for ovarian transplantation including back muscle (BM)

1931

DANESHPOYA et al. / Turk J Med Sci
(11), the retroperitoneum (12), under the kidney capsule
(13), subcutaneous sites (8), and granulation tissue
(GT) (14). Because of rapid revascularization, ovarian
transplantation under the kidney capsule site is common
(13). Youm et al. showed that the kidney capsule site, in
comparison to BM and subcutaneous sites, is the optimal
site for ovarian transplantation in the murine model (15).
Soleimani et al. found that ovarian graft into the BM had
some advantages compared to the kidney capsule because
of good angiogenesis conditions (11). Other investigators
found that grafting ovarian tissue into the ovarian bursa is
better than grafting under the kidney capsule, which itself
is better than a subcutaneous site (16).
Wound-healing GT is a promising site for ovarian
transplantation as reported by Israely et al. Their study
also showed an improvement in graft vascularization and
follicle survival (14). The new blood formation in GT is a
crucial component that transports nutrients, inflammatory
cells, and oxygen to the wound location (17). Moreover,
it has been shown that at the site of surgical operations,
tumor angiogenesis and growth are accelerated (18).
There is no report to compare and evaluate the efficacy
and influence of the GT site for ovarian transplantation
with other heterotopic sites such as the kidney capsule,
BM, and subcutaneous sites.
Some researchers have tried to identify factors such
as antioxidants (19), gonadotropin hormones (16),
and growth factors (20) that can decrease IR injury
during postimplantation by enhancing and establishing
angiogenesis in the grafted ovary.
N-acetylcysteine (NAC) is an antioxidant and a
precursor of glutathione and is used as a mucolytic agent
and also as treatment for paracetamol (acetaminophen)
overdose (21). Experimental studies have indicated the
protective effects of NAC on IR injuries of various organs,
such as the liver, lungs, kidneys, and ovary (22–25). Other
studies have demonstrated that using NAC in patients
with polycystic ovarian syndrome improves sensibility
to insulin (26). In addition, it has been proven that NAC
can inhibit apoptosis and promote cell survival (27).
Mahmoodi et al. showed that NAC improves follicular
survival in mice ovarian autografts into the BM by
decreasing oxidative stress and apoptosis (25). Amorim
et al. also reported that subcutaneous injection of NAC at
a high dose improves follicular survival of ovarian tissue
grafted into a retroperitoneal position (28).
Considering the easy access to GT for ovarian grafts
and the beneficial effects of NAC in experimental studies,
the aim of the current study was to investigate the effects of
NAC on ovarian autografts and also to compare the effect
of graft site (the GT versus the BM) on the survival rate of
fresh ovarian autografts in rats.
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2. Materials and methods
2.1. Animals
Twenty-eight adult female Wister rats were used in this
study. They had unlimited access to food and water and
were kept under standard conditions of a daily cycle of 12
h of light and 12 h of darkness.
The animals were randomly divided into four groups
(seven rats per group) as follows: Group 1, ovarian tissue
autografted into the GT and treated with saline (GT +
saline); Group 2, ovarian tissue autografted into the GT and
treated with NAC (Zambon S.P.A, Italy) at a dose of 150
mg/kg (GT + NAC); Group 3, ovarian tissue autografted
into the BM and treated with saline (BM + saline); Group
4, ovarian tissue autografted into the BM and treated with
NAC (BM + NAC). All the groups received injections
intraperitoneal from 2 days before surgery until 7 days
after grafting. The doses of NAC were selected according to
previous studies (25,29). After 28 days, the ovarian tissue
was removed from the transplantation site and histological
evaluations were performed.
2.2. Ovarian retrieval and transplantation
The animals were anesthetized with an intraperitoneal
injection of ketamine (60 mg/kg, ketamine 10% Alfasan,
Woerden, the Netherlands) and xylazine (10 mg/kg,
xylazine 2%; Alfasan). Before the surgery, the dorsal skin
of each rat was shaved and then swabbed with alcohol.
Then, under sterile conditions, bilateral incisions were
made on each side of the spine column and a bilateral
ovariectomy was performed. The ovarian blood vessels
were cauterized in order to stop the bleeding. The excised
ovaries of each rat were placed in a dish with normal
saline, removed out of periovarian fat, and cut in two
halves and then immediately autografted either into the
BM or into wound-healing GT. The muscle and skin were
then sutured.
To prepare wound-healing GT, a 0.5-cm full-thickness
dermal incision was made in the back of each rat by scalpel.
The incision was closed by 4/0 sutures. Four days later,
after removal of the sutures and excessive tissues, ovarian
tissue was autografted into the wound and sutured (14).
2.3. Vaginal smear collection
The vaginal smear of each rat was obtained at 0800–0900
hours before surgical procedures with a swab imbibed
in physiological solution on a standard slide and was
immediately observed under a light microscope (40×) in
order to be categorized as preestrous, estrous, or diestrous
depending on the cells found in the smears. The ovarian
transplantation was performed during the diestrous phase
(12,30).
2.4. Histological assessment
After 28 days, rats were reanesthetized with an injection
of ketamine and xylazine. The blood and ovarian tissue
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were obtained for hormonal analysis and histological
assessment, respectively.
The ovarian samples were rapidly fixed in 10% formalin
solution (Asia Chemical Co., Tehran, Iran) for 24 h and
were completely processed and embedded in paraffin
and blocked. Sections of 5-µm slides were stained with
hematoxylin and eosin (Merck, Darmstadt, Germany).
In order to evaluate the follicular development and
blood vessel density, ovarian follicles and blood vessels
were counted in four fields per section per animal at
100× magnification. Follicles were categorized into three
groups: immature (follicles including primordial, primary,
and preantral), antral, and corpus luteum. Primordial
follicles consist of the oocyte surrounded by a single
layer of follicular (granulosa) cells. Primary follicles are
distinguished by more than one layer of follicular cells
surrounding the oocyte. Preantral follicles are follicles
containing an oocyte surrounded by follicular cells layers
that still lack an antrum. Antral follicles are follicles
with only one cavity adjacent to the oocyte (8,12,28). All
microscopic assessments were performed at least by two
blinded investigators.
2.5. TUNEL assay
Apoptosis was assessed by TUNEL in accordance with the
kit manufacturer’s manual (In Situ Cell Death Detection
Kit; Roche, Berlin, Germany). Briefly, after the samples
were deparaffinized and rehydrated, they were washed
in phosphate-buffered saline (PBS; Sigma, St. Louis, MO,
USA) for 5 min, three times. Then they were exposed to
proteinase K (Sigma) for 15–30 min at room temperature.
Once again, they were washed in PBS and then the samples
were embedded in 0.3% H2O2 (Asia Chemical Co.) for 10–
15 min at 15–25 °C in the dark. After washing in PBS, the
TUNEL reaction mixture was added to the samples in the
dark and kept for 1 h at room temperature but was not
added to the other sample (i.e. the negative control). Then
they were all washed in PBS. Converter-POD (Roche)
was added to the samples, followed by incubation in a
humidified chamber for 30 min at 37 °C. Once again, they
were washed in PBS. Following that, the samples were
stained with diaminobenzidine (Sigma) and were then
incubated at 15–25 °C for 10 min in the dark, followed by
a wash in PBS. Hematoxylin (Merck) was used for nuclear
staining. The samples were washed with distilled water,
dehydrated, and embedded in ethanol (Merck) and finally
in xylene (Asia Chemical Co.). The apoptotic index was
determined as the percentage of granulosa cells yielding
apoptosis in 1000 cells from the tissue under a microscope
in high power fields (400×) (31).
2.6. Hormonal assay
After 28 days, blood samples were obtained and centrifuged
(3000 × g, 10 min). Next, serum was analyzed in duplicate
with the E2 and progesterone hormones being measured

within assay precision by ELISA kits (Monobind Inc., Lake
Forest, CA, USA) in accordance with the manufacturer’s
instructions.
2.7. Measurement of MDA concentration
MDA is a lipid peroxidation product used as the marker
of oxidative stress. It was evaluated in blood serum on the
28th day after transplantation using an ELISA kit (Shanghai
Crystal Day Biotech Co. Chain, Shanghai, China) in
accordance with the manufacturer’s instructions.
2.8. Statistical analysis
Data analyses were conducted using SPSS 16.0, applying
one-way analysis of variance (ANOVA) and Tukey’s test. P
< 0.05 was accepted as statistically significant.
3. Results
3.1. Number of follicles
The mean numbers of immature follicles, antral follicles,
and corpus lutea in the NAC-treated groups were higher
than in the saline groups. There were no significant
differences, however, among all the groups as shown in
Table 1 and Figure 1.
3.2. Number of blood vessels
The mean number of blood vessels in ovarian tissue was
significantly higher in the GT+NAC group compared to
GT+saline and BM+saline groups (P < 0.05 and P < 0.001
respectively). Moreover, the mean number of blood vessels
in the GT + NAC group was significantly higher than that
in BM + NAC group (P < 0.001), as shown in Table 2 and
Figure 2.
3.3. Apoptosis assay
As shown in Figures 3 and 4, the percentage of ovarian
apoptosis in the GT + NAC group was significantly lower
than that in the GT+saline and BM+NAC groups (P <
0.05).
3.4. Concentration of malondialdehyde
Despite the low level of MDA in the NAC-treated groups,
there were no significant differences among groups (Table 1).
3.5. Hormonal assay
Despite the high amount of estrogen and progesterone
hormones in the NAC-treated groups, there were no
significant differences among the groups. These results are
shown in Table 1.
4. Discussion
In the present study, in order to find out the most
suitable location for transplantation, rat ovaries were
autografted into two different sites, namely the BM and
wound-healing GT. Furthermore, we treated the rats with
NAC to determine its effects on follicular survival and
ovarian function. In this study, bilateral ovariectomy was
performed to prevent any ovarian hormonal secretions
that help the better follicular development by increasing
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Table 1. Comparison of the mean number of different follicles and corpus lutea and the levels of E2, progesterone, and MDA in different
groups of rats 28 days after ovarian tissue transplantation. GT + saline group, ovarian graft in granulation tissue, saline-treated; GT +
NAC group, ovarian graft in granulation tissue, NAC-treated (150 mg/kg); BM + saline group, ovarian graft in back muscle, salinetreated; BM + NAC group, ovarian graft in back muscle, NAC-treated.
Groups

Immature
follicles

Antral follicles

Corpus lutea

E2 (pg/mL)

Progesterone
(ng/mL)

MDA (nmol/
mL)

GT + saline

5.4 ± 1.14

1.33 ± 0.81

2.83 ± 1.47

48.13 ± 7.64

23.19 ± 4.53

19.5 ± 2.63

GT + NAC

6.8 ± 1.09

1.83 ± 1.47

4.16 ± 2.13

60.77 ± 6.81

27.85 ± 6.1

17.96 ± 3.31

BM + saline

5.6 ± 1.67

1.66 ± 1.03

1.66 ± 0.81

59.31 ± 8.97

23.57 ± 3.51

18.82 ± 2.07

BM + NAC

7.2 ± 1.48

2 ± 0.63

5.83 ± 3.43

66.91 ± 7.61

26.55 ± 6.64

15.11 ± 2.15

All values represent mean ± SD. One-way analysis of variance and Tukey’s test showed no statistically significant differences.

Figure 1. Photomicrographs of rat ovarian tissues (sections stained with H&E) in four groups 28 days after transplantation: A) ovarian
graft in granulation tissue, saline-treated; B) ovarian graft in granulation tissue, NAC-treated; C) ovarian graft in back muscle, salinetreated; D) ovarian graft in back muscle, NAC-treated. Arrows showing follicles, CL showing corpus luteum, and M showing muscle.
Original magnification: 100×.
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Table 2. Comparison of the mean number of vessels in different groups of rats 28 days
after ovarian tissue transplantation. GT + saline group, ovarian graft in granulation
tissue, saline-treated; GT + NAC group, ovarian graft in granulation tissue, NAC-treated
(150 mg/kg); BM + saline group, ovarian graft in back muscle, saline-treated; BM +
NAC group, ovarian graft in back muscle, NAC-treated.
Groups

Number of vessels

GT + saline

32.85 ± 5.45a

GT + NAC

44.28 ± 5.7bc

BM + saline

14.28 ± 1.6

BM + NAC

23.42 ± 1.51d

Values are means ± SD.
a
P < 0.001 compared to corresponding value of BM + saline group.
b
P < 0.05 compared to corresponding value of GT + saline group.
c
P < 0.001 compared to corresponding value of BM + NAC group.
d
P < 0.05 compared to corresponding value of BM + saline group.

Figure 2. Macroscopic images of rat ovarian tissues 28 days after transplantation in granulation tissue saline-treated group (A) and
NAC-treated group (B). Arrows showing ovary and arrow heads showing neovascularization adjacent to the graft.

gonadotropins (13). The treatment groups received NAC
injections from 2 days before graft surgery until 7 days
after transplantation to obtain better results. A dose of 150
mg/kg NAC was chosen, which was shown to be the most
effective in reducing IR injury (25,29).
In this study, the histological sections clearly showed
that neovascularization in ovaries grafted into the GT
was higher than in those grafted into BM. Furthermore,
we confirmed the better survival of follicles, through
preventing apoptosis, in the GT graft site compared to
the BM graft site. We also confirmed that NAC helps this
process and enhances neovascularization in both graft
sites.
Furthermore, in the present study, the recovery rates of
the ovarian grafts transplanted into the GT and BM were

100%. In addition, stromal tissue, which has an important
role in tissue integrity, was normal.
The site of the ovarian graft affected the recovery of
the graft and the number of oocytes retrieved. The kidney
capsule graft site has a rich blood supply that promotes
the revascularization process, which is vital for recovery
of the graft and the support of follicular growth. The
main cause of graft and follicle loss in the process of
ovarian transplantation is believed to be ischemia after
transplantation (32). In mice, ovarian transplantation
accounts for approximately 42% of the loss of follicle
population (33).
Duration of the ischemia before revascularization and
survival of transplanted ovarian tissue depend on several
factors, such as the size of the tissue, the graft site, and the

1935

DANESHPOYA et al. / Turk J Med Sci

Figure 3. Histological assessment of apoptosis by TUNEL staining in ovarian tissue 28 days after transplantation: A) ovarian graft in
granulation tissue, saline-treated; B) ovarian graft in granulation tissue, NAC-treated; C) ovarian graft in back muscle, saline-treated;
D) ovarian graft in back muscle, NAC-treated; E) ovarian tissue, negative control TUNEL staining. Arrows indicate TUNEL-positive
granulosa cells (dark brown nucleus). Original magnification: 400×.
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Apoptosis index(%)

25
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*#

15
10
5
0

GT+saline

GT+NAC

BM+saline
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Groups

Figure 4. Comparison of apoptosis rate of granulosa cells in
different groups of rats 28 days after ovarian transplantation.
Values are means ± SD.
*: P < 0.05 vs. GT+saline.
#: P < 0.05 vs. BM+NAC.

presence of angiogenic factors (32). Revascularization of
ovaries in rodents occurred within 24–48 h after grafting
(9).
Israely et al. showed that subcutaneous grafts have
no adequate blood supply and varied vascular integrity
(34). Callejo el al. reported that revascularization of
transplanted ovarian tissue into the ovarian bursa is better
than revascularization in other heterotopic ovarian graft
sites (35).
The BM site supports murine ovarian graft survival
and has shown its unique capacity to preserve the follicles,
which is likely due to rapid vessel formation and better
support of blood in the grafted site (11). Soliemani et al.
compared the kidney site to the BM site and showed that
the BM site provides better support for neovascularization
with a specific blood stream generation in the graft site
(11). Their results were confirmed by findings suggesting
that there are significantly higher numbers of blood
vessels in the BM than in the kidney site. Our histological
evaluation showed that the number of blood vessels is
significantly higher in the GT than in the BM site, and this
is probably due to the rich content of angiogenic factors
such as vascular endothelial growth factor. Apart from
the benefits in terms of better follicular survival and rich
neovascularization around the site of grafting in the GT
side, graft accessibility is an additional benefit of this site
compared to the other sites of grafts.
According to a previous study conducted by Dissen
et al., neovascularization after ovarian transplantation
occurred within 42 h in rats and during neovascularization
the ovarian tissue grafts are susceptible to ischemia and
hypoxia (9). Therefore, reducing the ischemia time after
transplantation is vital to the successful restoration of
ovarian function (15). It could be deduced that GT is a

good site for ovarian transplantation because it provides
a supportive neovascularization environment in the graft
site.
Our results also demonstrated that the apoptosis rate
of ovarian granulosa cells in the wound-healing GT site
was lower than in the BM site, and NAC attenuated it in
both NAC-treated groups. The beneficial effects of NAC
on the reduction of apoptosis rates have been shown by
other investigators, as well (25).
Prevention of apoptosis by NAC may be achieved
through inhibiting the production of preinflammatory
cytokines such as tumor necrosis factor alpha and
interleukin-1 beta, inducible nitric oxide synthase, and
nitric oxide production, which have important functions
in IR injury (36).
Although it was found in this study that NAC had an
antiapoptotic effect, it could not reduce the relevance of IR
injury after ovarian transplantation in graft sites, such as
recovery of ovarian follicles or levels of progesterone and
estradiol hormones. These results are inconsistent with
those of the previous studies. This could be because the
NAC administration method in rats, in terms of duration
and given doses, was not adequate for ovary endocrine
function recovery. Moreover, severe injuries to the ovary
in the first days of ischemia before neovascularization
should also be considered. In addition, the inadequate
delivery of gonadotropin to grafts by the vascular
remodeling that happens in the ovarian graft and the low
number of follicles in the ovarian grafts might be the other
reasons (33). However, more studies with modified doses,
treatment duration, and NAC administration method may
improve the obtained results.
Collectively, data from this study indicate that
developing follicles in ovarian grafts by NAC, irrespective
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of the graft location, do not correct the disturbance of
hormonal feedback between the pituitary and ovary
induced by grafting.
In conclusion, our study showed that the woundhealing GT is an optimal site and is better in terms of the
richness of neovascularization and reduction of apoptosis
than the BM site for ovarian tissue grafting in the rat model.
Moreover, we confirmed that despite the antiapoptotic

effect of NAC, it could not restore autografted ovarian
functions.
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